Literature DB >> 28642300

Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Tamara P Miller1,2,3, Yimei Li1,4, Marko Kavcic1, Kelly D Getz1,2, Yuan-Shun V Huang2, Lillian Sung5, Todd A Alonzo6,7, Robert Gerbing7, Marla H Daves8, Terzah M Horton8, Michael A Pulsipher9, Jessica Pollard10, Rochelle Bagatell1,11, Alix E Seif1,11, Brian T Fisher2,4,11,12, Selina Luger13, Alan S Gamis14, Peter C Adamson1,11, Richard Aplenc15,2,3,11.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28642300      PMCID： PMC5685242          DOI： 10.3324/haematol.2017.168815

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

2.  Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice.

Authors:  Angèle Gros; Varouna Syvannarath; Lamia Lamrani; Véronique Ollivier; Stéphane Loyau; Tobias Goerge; Bernhard Nieswandt; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  Blood       Date:  2015-06-02       Impact factor: 22.113

3.  Reliability of adverse symptom event reporting by clinicians.

Authors:  Thomas M Atkinson; Yuelin Li; Charles W Coffey; Laura Sit; Mary Shaw; Dawn Lavene; Antonia V Bennett; Mike Fruscione; Lauren Rogak; Jennifer Hay; Mithat Gönen; Deborah Schrag; Ethan Basch
Journal:  Qual Life Res       Date:  2011-10-08       Impact factor: 4.147

4.  Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.

Authors:  Christelle Nonne; Nadège Lenain; Béatrice Hechler; Pierre Mangin; Jean-Pierre Cazenave; Christian Gachet; François Lanza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-17       Impact factor: 8.311

5.  AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.

Authors:  Todd M Cooper; Janet Franklin; Robert B Gerbing; Todd A Alonzo; Craig Hurwitz; Susana C Raimondi; Betsy Hirsch; Franklin O Smith; Prasad Mathew; Robert J Arceci; James Feusner; Robert Iannone; Robert S Lavey; Soheil Meshinchi; Alan Gamis
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

6.  Factors affecting workload of cancer clinical trials: results of a multicenter study of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  Kathyrn Roche; Nancy Paul; Bobbi Smuck; Marlo Whitehead; Benny Zee; Joseph Pater; Mary-Anne Hiatt; Hugh Walker
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

7.  Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition.

Authors:  T M Getz; R Piatt; B G Petrich; D Monroe; N Mackman; W Bergmeier
Journal:  J Thromb Haemost       Date:  2015-01-09       Impact factor: 5.824

Review 8.  Adverse event reporting in cancer clinical trial publications.

Authors:  Shanthi Sivendran; Asma Latif; Russell B McBride; Kristian D Stensland; Juan Wisnivesky; Lindsay Haines; William K Oh; Matthew D Galsky
Journal:  J Clin Oncol       Date:  2013-12-09       Impact factor: 44.544

9.  Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.

Authors:  Ursula Creutzig; Martin Zimmermann; Jean-Pierre Bourquin; Michael N Dworzak; Gudrun Fleischhack; Norbert Graf; Thomas Klingebiel; Bernhard Kremens; Thomas Lehrnbecher; Christine von Neuhoff; Jörg Ritter; Annette Sander; André Schrauder; Arend von Stackelberg; Jan Starý; Dirk Reinhardt
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

10.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.

Authors:  Patrick Andre; Suzanne M Delaney; Thomas LaRocca; Diana Vincent; Francis DeGuzman; Marzena Jurek; Beverley Koller; David R Phillips; Pamela B Conley
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808
View more
  2 in total

1.  Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events.

Authors:  Tamara P Miller; Brian T Fisher; Kelly D Getz; Leah Sack; Hanieh Razzaghi; Alix E Seif; Rochelle Bagatell; Peter C Adamson; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2019-04-09       Impact factor: 3.167

2.  Impact of fluid overload and infection on respiratory adverse event development during induction therapy for childhood acute myeloid leukemia.

Authors:  Lane H Miller; Frank Keller; Ann Mertens; Mitchel Klein; Kristen Allen; Sharon Castellino; William G Woods
Journal:  Pediatr Blood Cancer       Date:  2019-09-10       Impact factor: 3.167
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.